Opendata, web and dolomites

ASTAOMEGA SIGNED

IMPLEMENTATION OF A SUSTAINABLE AND COMPETITIVE SYSTEM TO SIMULTANEOUSLY PRODUCE ASTAXANTHIN AND OMEGA-3 FATTY ACIDS IN MICROALGAE FOR ACQUACULTURE AND HUMAN NUTRITION

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ASTAOMEGA" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI VERONA 

Organization address
address: VIA DELL ARTIGLIERE 8
city: VERONA
postcode: 37129
website: www.univr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 149˙995 €
 EC max contribution 149˙955 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI VERONA IT (VERONA) coordinator 149˙955.00

Map

 Project objective

This project aims at developing an innovative and commercially competitive production platform for high value products as Astaxanthin and Omega-3, to be used for human nutrition or aquaculture. Astaxanthin is a pigment primary produced by microalgae: this carotenoid has a strong antioxidant power and it is used in different fields as healthcare, food/feed supplementation and as pigmenting agent in aquaculture. However, cultivation of the main microalgae species producing Astaxanthin is costly due to low biomass productivity or low Astaxanthin content, causing an extremely high price of this molecule on the market. Marine microalgae are also the primary producers of Omega-3, very long chain fatty acids, essential components of high quality diets for humans, being related to cardiovascular wellness, and proper visual and cognitive development. However, due to the high cost of microalgae cultivation, the market of Omega-3 is mostly based on fish or krill oils, with high costs and environment impacts associated. New sources of Astaxanthin and Omega-3 must thus be implemented: based on the results obtained in ERC-Stg-SOLENALGAE, an innovative, low cost and high productive strategy can be proposed for simultaneous Astaxanthin and Omega-3 production in the robust and fast growing marine microalgae species Nannochloropsis gaditana. The main objectives of the ASTAOMEGA project will be: 1. To validate to a demonstration stage the ASTAOMEGA system 2. The assessment of the market size and market requirements, through extensive market analysis 3. The identification of the best suitable commercial route to be undertaken to take the ASTAOMEGA system to the market, as inception of a spin-off company and/or the licensing agreements on the IPR exploitation with the interested end-users (see LOIs). The ASTAOMEGA team is confident that the outcomes of this project are poised to exert a beneficial impact on the European microalgae industry and nutraceuticals market

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTAOMEGA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTAOMEGA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

E-DIRECT (2020)

Evolution of Direct Reciprocity in Complex Environments

Read More  

REPLAY_DMN (2019)

A theory of global memory systems

Read More  

Host-TB (2019)

Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis

Read More